Agilon Health Revised 2023 Medical Margin Expectation To $340M-$360M, Approximately $110M Below The Previous Guidance; Sees FY23 Revenue Of $4,295B-$4,305B Vs. $4.53B Estimate (Prior View: $4.310B-$4.320B); Says Timothy Bensley To Reire As CFO
Portfolio Pulse from Benzinga Newsdesk
Agilon Health has lowered its 2023 medical margin forecast to $340M-$360M, which is about $110M below its previous guidance. The company also adjusted its full-year 2023 revenue projection to $4.295B-$4.305B, compared to the prior estimate of $4.53B and previous guidance of $4.310B-$4.320B. Additionally, Agilon Health announced the retirement of CFO Timothy Bensley.
January 05, 2024 | 11:19 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Agilon Health has revised its 2023 medical margin expectation significantly lower and reduced its revenue forecast, which is now below analyst estimates. The company also announced the retirement of its CFO, Timothy Bensley.
The downward revision in Agilon Health's medical margin and revenue guidance is likely to negatively impact investor sentiment and the stock price in the short term. The retirement of the CFO could add to the uncertainty and potential concerns about the company's financial management.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100